NCT07754474RecruitingPhase 1
A study to test how well different and multiple doses of BI 3034701 are tolerated in people living with overweight or obesity
Source: EU CTIS (euclinicaltrials.eu) · Last updated 18 Aug 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- First submitted
- 19 Jun 2026
- Start date
- 18 Aug 2026
- Lead sponsor
- Boehringer Ingelheim International GmbH
- Diseases
- Obesity
- EU CT number
- 2026-526090-42-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 35
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CRS Clinical Research Services Management GmbH Coordinator of this site? Confirm its status | Mannheim | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.